Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent (COMPARE-II)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2014 by Maasstad Hospital.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Maasstad Hospital Identifier:
First received: October 28, 2010
Last updated: January 29, 2014
Last verified: January 2014